E-drug: MaLAM International editions now available
-------------------------------------------------------------------------
Dear E-druggers,
3 "new" editions of MaLAM International News are now available on
the www at:
www.camtech.net.au/malam/Inter.htm
(If you do not have access to www then see below)
The editions are:
March/April 2000 Vol 18 No 3/4
Healthy Scepticism about Pfizer and Searle�s promotion of celecoxib
in Australia
January/February 2000 Vol 18 No 1/2
SKB promotes Augmentin (amoxicillin and potassium clavulinate) in
Central America with the claim that "generic producers do not reach
the standard of quality of SmithKline Beecham".
November/December 1999 Vol 17 No 11/12
Ethics vs Morality (We are proud to publish this beautifully written
article about dilemmas for community pharmacists written by Raj
Vaidya, a community pharmacist in Goa, India.)
If you would like to be notified of all future editions then there are 2
options:
If you have access to E-mail and to the www then please E-mail
mintwww-request@camtech.net.au with the word "subscribe" in the
text of your message without the quotation marks and with no other
words in the message. This is the best option because it enables you
to see pictures of the advertisements.
If you have access to E-mail but not to www then please E-mail:
mintemail-request@camtech.net.au with the word "subscribe" in the
text of your message without the quotation marks and with no other
words in the message. That will enable you to get future editions text
only, no pictures. If you want any of the current editions and do not
have access to the www then please ask me.
Regards,
Peter
Dr Peter Mansfield
GP and consultant on marketing and quality use of medicines
Visiting lecturer, Universities of Adelaide, Flinders, South Australia,
Tasmania
Cardiovascular adviser, Adelaide Western Division of General Practice
Quality Use of Medicines Coordinator, Southern (Adelaide) Division of
General Practice
Primary author, Healthy Scepticism
Director, MaLAM (Medical Lobby for Appropriate Marketing)
MaLAM aims to protect compassionate scientific health care from
marketing practices that may be detrimental to health.
peter.mansfield@flinders.edu.au
www.camtech.net.au/malam
PO Box 172 Daw Pk SA 5041 Australia
ph/fax +61 8 8374 2245
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.